Parameter | Adjusted overall change (95% CI)* | P†| ||
---|---|---|---|---|
Ipragliflozin | Sitagliptin | Difference | Interaction | |
Glucose metabolism | Â | Â | Â | Â |
 FPG (mmol/L) | −1.28 (− 1.56; −1.00) | −1.24 (− 1.51; −0.96) | 0.83 | 0.04 |
 Insulin (pmol/L) | −8.51 (− 14.7; −2.34) | −3.83 (− 9.39; 1.74) | 0.27 | 0.75 |
 HbA1c (%) | −0.33 (− 0.45; −0.22) | −0.44 (− 0.55; −0.33) | 0.19 | 0.14 |
 GA (%) | −1.97 (− 2.35; −1.58) | −2.07 (− 2.44; −1.69) | 0.72 | 0.29 |
Lipids | Â | Â | Â | Â |
 TC (mg/dL) | 1.7 (− 3.6; 6.9) | −1.8 (− 6.8; 3.3) | 0.36 | 0.84 |
 LDL-C (mg/dL) | 1.2 (− 3.1; 5.6) | 6.6 (1.6; 11.6) | 0.12 | 0.40 |
 HDL-C (mg/dL) | 2.3 (0.9; 3.6) | 0.0 (− 1.2; 1.3) | 0.02 | 0.59 |
 TG (mg/dL) | −12.7 (− 30.3; 4.9) | −23.1 (− 40.7; −5.4) | 0.42 | 0.92 |
Apolipoproteins | Â | Â | Â | Â |
 AI (mg/dL) | 2.26 (− 0.89; 5.40) | −1.68 (− 4.23; 0.87) | 0.06 | 0.86 |
 AII (mg/dL) | −0.51 (− 1.17; 0.16) | −0.18 (− 0.74; 0.39) | 0.46 | 0.26 |
 B (mg/dL) | −0.69 (− 3.90; 2.52) | −1.96 (− 4.74; 0.81) | 0.55 | 0.59 |
 B48 (µg/dL) | 0.45 (− 0.60; 1.49) | −1.39 (− 2.16; −0.61) | 0.006 | 0.11 |
 CII (mg/dL) | −0.21 (− 0.51; 0.09) | −0.40 (− 0.64; −0.17) | 0.31 | 0.71 |
 CIII (mg/dL) | −0.07 (− 0.85; 0.72) | −0.86 (− 1.38; −0.34) | 0.10 | 0.51 |
 E (mg/dL) | −0.30 (− 0.56; −0.05) | −0.09 (− 0.30; 0.11) | 0.21 | 0.91 |